News Moderna, Inc.

Equities

MRNA

US60770K1079

Pharmaceuticals

Real-time Estimate Cboe BZX Other stock markets 10:38:00 2026-02-17 EST			5-day change	1st Jan Change
42.24 ^USD	+0.02%		+0.28%	+42.80%

10:17am	Bernstein Adjusts Price Target on Moderna to $45 From $35, Maintains Market Perform Rating	MT
08:55am	RBC Capital Adjusts Price Target on Moderna to $30 From $25, Maintains Sector Perform Rating	MT

All News

10:17am	Bernstein Adjusts Price Target on Moderna to $45 From $35, Maintains Market Perform Rating	MT
08:55am	RBC Capital Adjusts Price Target on Moderna to $30 From $25, Maintains Sector Perform Rating	MT
08:09am	Moderna Gets Approval for COVID Vaccine From European Commission	MT
07:43am	Moderna receives European Commission marketing authorization for Covid-19 vaccine Mnexspike	RE
05:31am	Analyst recommendations: Accenture, Dollar Tree, DraftKings, Moderna, Walmart…
02-16	Berenberg Reiterates Sanofi at Buy on 'Significant' Share Discount	MT
02-13	Moderna : Earnings Transcript (MRNA USQ Transcript 2026 02 13)	PU
02-13	Health Care Up Amid Mixed Earnings - Health Care Roundup	DJ
02-13	Equities Mixed After CPI Data; Wall Street Sees Worst Week Since November	MT
02-13	Sector Update: Health Care Stocks Advance Late Afternoon	MT
02-13	Wall St indexes rises as tech steadies, inflation cools	RE
02-13	Equities Rise Intraday as Markets Parse CPI Report	MT
02-13	Sector Update: Health Care Stocks Higher Friday Afternoon	MT
02-13	Sector Update: Health Care	MT
02-13	RBC Raises Price Target on Moderna to $30 From $25, Keeps Sector Perform Rating	MT
02-13	Jefferies Raises Price Target on Moderna to $37 From $30	MT
02-13	Moderna, Inc. Reports Earnings Results for the Fourth Quarter and Full Year Ended December 31, 2025	CI
02-13	Moderna Maintains Full-Year Revenue Growth Outlook Following Fourth-Quarter Beat	MT
02-13	Moderna, Inc., Q4 2025 Earnings Call, Feb 13, 2026
02-13	Moderna Shares Rise After Q4 Loss Narrows, Revenue Beats Estimates	MT
02-13	Sector Update: Health Care Stocks Edge Higher Premarket Friday	MT
02-13	Moderna Reiterates 10% Revenue-Growth Target as Covid Vaccine Demand Falls -- Update	DJ
02-13	Sector Update: Health Care	MT
02-13	Moderna, Inc. Provides Earnings Guidance for the Fiscal Year 2026	CI
02-13	Moderna beats quarterly revenue estimates on resilient sales of COVID shot	RE

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages MarketScreener Editorial Features MarketScreener Strategies Trading Ideas

Filters

Headlines

Moderna in a Spin After FDA Declines to Review Flu Vaccine Candidate

February 11, 2026 at 10:13 am

Moderna Falls As FDA Vows To Impose New Vaccine Rules

December 01, 2025 at 03:32 pm